PUMA BIOTECHNOLOGY, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Los Angeles, CA
SEC filing record 1 source field available
Fiscal year end
31 December
PUMA BIOTECHNOLOGY, INC. has filed 1,112 SEC EDGAR filings since 14 Sep 2007

SEC filing history

Showing 151-175 of 1,000 matching filings.

Per page
25
Current page
7
DEFA14A File 001-35703

FORM DEFA14A

Filing date
26 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-35703

ARS filing

Filing date
26 Apr 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-35703

FORM DEF 14A

Filing date
26 Apr 2024
Reporting date
18 Jun 2024
Next action
Verify source filing
SC 13G File 005-83367

SC 13G

Filing date
29 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Mar 2024
Reporting date
15 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Feb 2024
Reporting date
12 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Feb 2024
Reporting date
12 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Feb 2024
Reporting date
12 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Feb 2024
Reporting date
12 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Feb 2024
Reporting date
12 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-83367

PRIMARY DOCUMENT

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-83367

SCHEDULE 13G/A

Filing date
13 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-83367

PUMA BIOTECHNOLOGY, INC.

Filing date
06 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-83367

SC 13G/A filing

Filing date
30 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 Jan 2024
Reporting date
04 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144/A File 001-35703

144/A filing

Filing date
10 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Jan 2024
Reporting date
03 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Jan 2024
Reporting date
03 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Jan 2024
Reporting date
03 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .